Opdivo monotherapy superior to Yervoy monotherapy in Stage-III/IV resected melanoma: https://finance.yahoo.com/news/phase-3-study-evaluating-safety-101500049.html There’s no direct commercial benefit for BMY in these results, as far as I can tell. The combination of Opdivo + Yervoy was not tested in this trial.